EEA Veterinary and Phytosanitary Standards 2026: what changes for agri-food exporters

Key data

Exports of animal and plant products to Norway, Iceland and Liechtenstein remain subject to the same health controls that apply in the EU, following the update of the European Economic Area regulatory framework. The Decision of the EEA Joint Committee No. 6/2026, adopted on 6 February 2026 and published on 21 May 2026, amends Annex I of the EEA Agreement, which specifically regulates veterinary and phytosanitary matters.

For companies in the agri-food, livestock and phytosanitary sectors, this means that the compliance framework does not change radically, but it does require verification that the new requirements incorporated are covered. Failure to act could lead to problems in export controls to these three markets.

What does this regulation establish?

The EEA Agreement allows Norway, Iceland and Liechtenstein to participate in the European single market without being EU members. For this to work, the EEA Joint Committee periodically updates the annexes of the Agreement to incorporate EU regulations as they are approved.

Decision 6/2026 updates Annex I, which covers exclusively veterinary and phytosanitary matters. By incorporating EU regulations into this annex, it ensures that the three non-EU EEA countries apply the same health standards as EU member states.

The practical result for Spanish exporting companies is as follows:

• The controls to which their animal and plant products are subject at destination (Norway, Iceland, Liechtenstein) are the same as those already applied in the EU.
• There are no differentiated health requirements for these three markets compared to the rest of the single market.
• The new requirements incorporated into Annex I must be verified by companies to ensure compliance.
• The measure facilitates intra-European trade by maintaining a uniform regulatory framework and reduces technical barriers.

Economic and operational impact

The direct impact of this decision is not a new cost in itself, but an obligation to verify and ensure compliance. Companies that already operate in accordance with EU veterinary and phytosanitary regulations have an advantage: their current standards are, in principle, valid for the three non-EU EEA markets.

However, operational risk appears if the company has not reviewed the new specific requirements incorporated into Annex I. A shipment rejected at the border for non-compliance with an updated health requirement can result in:

• Costs of returning or destroying goods.
• Loss of contracts with distributors in Norway, Iceland or Liechtenstein.
• Supply chain delays that affect commitments to customers.
• Possible administrative sanctions at origin for exporting without meeting current requirements.

The opportunity, on the other hand, is clear: by maintaining a uniform regulatory framework, companies that already comply with EU regulations can operate in these three markets without the need for additional adaptations, as long as they verify compliance with the new requirements incorporated.

Who does it affect?

Decision 6/2026 directly affects:

• Agri-food companies that export animal or plant origin products to Norway, Iceland or Liechtenstein.
• Livestock companies that market live animals or derived products to non-EU EEA countries.
• Veterinary sector companies whose products or services are regulated by EEA animal health regulations.
• Phytosanitary sector companies that export plants, seeds, vegetables or phytosanitary products to these three markets.
• Foreign trade advisors and consultants who manage export operations to the EEA.
• CFOs and operations directors of companies with supply chains that include Norway, Iceland or Liechtenstein.

Practical example

A Spanish Iberian ham producer that regularly exports to Norway has its health certifications aligned with EU regulations. Following the entry into force of Decision 6/2026 on 6 February 2026, Norway formally incorporates the new EU veterinary requirements into its regulatory framework through Annex I of the EEA Agreement.

If the company does not verify which specific requirements have been incorporated in this update, it runs the risk that in the next shipment Norwegian health authorities will detect non-compliance at some point in the certification chain. The result could be the retention of the shipment at the border, with the associated logistics and commercial costs.

The correct action is to review the new requirements incorporated into Annex I, compare them with the company's current certifications and, if there is any gap, correct it before the next shipment to any of the three affected countries.

What should companies do now?

1. Identify if you export to Norway, Iceland or Liechtenstein animal or plant origin products. If so, this regulation directly affects you.
2. Review the new requirements incorporated into Annex I of the EEA Agreement through Decision 6/2026 published in EUR-Lex to identify what specific changes have been introduced.
3. Compare the new requirements with your current health certifications to detect possible compliance gaps before your next shipment.
4. Consult with your foreign trade advisor or official veterinarian if you detect doubts about compliance with any specific requirement incorporated.
5. Update export documentation if any of the new requirements require additional certificates, declarations or controls.
6. Communicate the changes to your logistics and operations team so that the next shipments to the three affected countries include updated health documentation.